Comparative Efficacy of Flunarizine and Propranolol in Pediatric Migraine Using the PedMIDAS Measuring Tool
Objectives: This study aimed to evaluate the efficacy of flunarizine and propranolol in reducing migraine frequency in children aged 8–15 years using the PedMIDAS score.Methodology: A Prospective, randomized, open-label, comparative clinical trial was conducted at the Pediatric Neurology Outpatient Department, The Children’s Hospital Lahore. Participants were randomized into two groups: Group-A (Flunarizine) and Group-B (Propranolol). Follow-up visits were conducted at six and 12 weeks to review diaries, assess side effects, ensure compliance, and re-evaluate PedMIDAS scores with pre-intervention PedMIDAS score. Data was analyzed by SPSS version 22.Results: The mean duration of migraine episode was 3.91 ± 1.4 hours and 3.20 ± 1.4 hours in propranolol and flunarizine group respectively. The baseline PedMEDIAS score of propranolol and flunarizine group were 28.45 ± 7.6 and 27.95 ± 7.5 respectively, on follow up, propranolol group reported 19.1 ± 8.1 score and in flunarizine group it was 17.5 ± 8.3 score. Over all PedMEDIAS score reduction was 9.3 ± 3.1 versus 10.4 ± 2.9 in propranolol versus flunarizine group respectively but the results were not significant (p-value ≥0.05). The main primary outcome was reduction in headache frequency and was found in 10 (45.4%) participants of propranolol group and 13(59.1%) participants of flunarizine group.Conclusion: It can be concluded that flunarizine is slightly better in efficacy than propranolol, for the preventive treatment of migraine in children.
Authors
- Shumaila Rafique
- Muhammad Zia Ur Rehman
- Tipu Sultan (ORCID: https://orcid.org/0000-0001-9398-2127)
- Ishfaq Ahmed
Institutions
- University of Child Health Sciences (PK)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2026-11-21
- DOI
- https://doi.org/10.12669/pjms.42.12.20120
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00